1. P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). (23rd June 2022) Authors: Locatelli, F.; Zugmaier, G.; Rizzari, C.; Morris, J.; Gruhn, B.; Klingebiel, T.; Parasole, R.; Linderkamp, C.; Flotho, C.; Petit, A.; Micalizzi, C.; Zeng, Y.; Desai, R.; Kormany, W.; Eckert, C.; Möricke, A.; Sartor, M.; Hrusak, O.; Peters, C.; Saha, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1760: AZACITIDINE AS TREATMENT OF KMT2A INFANT ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE. (23rd June 2022) Authors: Giagnuolo, G.; De Matteo, A.; Stellato, P.; Petruzziello, F.; Cuccurullo, R.; Beneduce, G.; Cacace, F.; Tambaro, F. P.; Parasole, R.; Menna, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗